Altimmune (NASDAQ:ALT) said it has strengthened its balance sheet and is preparing to begin a global Phase 3 trial of ...
Many drug and antibody discovery pathways focus on intricately folded cell membrane proteins. When molecules of a drug ...
Isomorphic, which formed as an Alphabet company in 2021, has a massive cash horde, but it’s tight-lipped on what drugs it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results